Israel Englander Brainstorm Cell Therapeutics Inc. Transaction History

Millennium Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $252,736 - $404,377	126,368 Added 1125.57%	137,595 $283,000
Q1 2023 May 15, 2023	SELL	$1.43 - $3.3 $43,459 - $100,290	-30,391 Reduced 73.02%	11,227 $37,000
Q4 2022 Feb 14, 2023	SELL	$1.37 - $4.42 $139,385 - $449,695	-101,741 Reduced 70.97%	41,618 $68,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $4.42 $85,075 - $147,464	33,363 Added 30.33%	143,359 $634,000
Q2 2022 Aug 15, 2022	SELL	$2.71 - $3.6 $84,706 - $112,525	-31,257 Reduced 22.13%	109,996 $304,000
Q1 2022 May 16, 2022	SELL	$2.92 - $4.19 $26,025 - $37,345	-8,913 Reduced 5.94%	141,253 $475,000
Q4 2021 Feb 14, 2022	SELL	$2.81 - $4.23 $452 - $681	-161 Reduced 0.11%	150,166 $601,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $694,357 - $904,433	-221,133 Reduced 59.53%	150,327 $496,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $4.01 $1.12 Million - $1.49 Million	371,460 New	371,460 $1.41 Million
Q1 2021 May 17, 2021	SELL	$3.46 - $7.88 $182,210 - $414,976	-52,662 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $210,121 - $933,697	52,662 New	52,662 $238,000
Q3 2020 Nov 16, 2020	SELL	$11.19 - $16.92 $160,833 - $243,191	-14,373 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.42 - $12.66 $811,861 - $2.33 Million	-183,679 Reduced 92.74%	14,373 $161,000
Q1 2020 May 14, 2020	BUY	$4.01 - $8.88 $794,188 - $1.76 Million	198,052 New	198,052 $919,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $68.6M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.